A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors

NCT02705963 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Trametinib
DRUG: Trametinib
DRUG: Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol)

Sponsor

Novartis Pharmaceuticals